X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES GSK PHARMA ALKEM LABORATORIES/
GSK PHARMA
 
P/E (TTM) x - 60.1 - View Chart
P/BV x 6.1 11.8 51.9% View Chart
Dividend Yield % 0.7 2.1 33.9%  

Financials

 ALKEM LABORATORIES   GSK PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
GSK PHARMA
Mar-16
ALKEM LABORATORIES/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,5893,850 41.3%   
Low Rs1,2322,966 41.5%   
Sales per share (Unadj.) Rs417.5332.3 125.6%  
Earnings per share (Unadj.) Rs56.344.3 127.1%  
Cash flow per share (Unadj.) Rs64.747.2 137.0%  
Dividends per share (Unadj.) Rs12.7050.00 25.4%  
Dividend yield (eoy) %0.91.5 61.4%  
Book value per share (Unadj.) Rs292.9202.7 144.5%  
Shares outstanding (eoy) m119.5784.70 141.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.410.3 32.9%   
Avg P/E ratio x25.176.9 32.6%  
P/CF ratio (eoy) x21.872.2 30.2%  
Price / Book Value ratio x4.816.8 28.6%  
Dividend payout %22.6112.9 20.0%   
Avg Mkt Cap Rs m168,653288,643 58.4%   
No. of employees `000NA4.6 0.0%   
Total wages/salary Rs m9,1714,434 206.8%   
Avg. sales/employee Rs ThNM6,104.5-  
Avg. wages/employee Rs ThNM961.6-  
Avg. net profit/employee Rs ThNM813.7-  
INCOME DATA
Net Sales Rs m49,91528,148 177.3%  
Other income Rs m1,6451,218 135.0%   
Total revenues Rs m51,56129,366 175.6%   
Gross profit Rs m8,4824,774 177.7%  
Depreciation Rs m1,006248 405.6%   
Interest Rs m6710-   
Profit before tax Rs m8,4515,744 147.1%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m026 0.0%   
Tax Rs m1,6062,018 79.6%   
Profit after tax Rs m6,7313,752 179.4%  
Gross profit margin %17.017.0 100.2%  
Effective tax rate %19.035.1 54.1%   
Net profit margin %13.513.3 101.2%  
BALANCE SHEET DATA
Current assets Rs m27,06221,462 126.1%   
Current liabilities Rs m15,32410,536 145.4%   
Net working cap to sales %23.538.8 60.6%  
Current ratio x1.82.0 86.7%  
Inventory Days Days6768 98.3%  
Debtors Days Days4116 251.4%  
Net fixed assets Rs m12,6104,717 267.3%   
Share capital Rs m239847 28.2%   
"Free" reserves Rs m34,49016,308 211.5%   
Net worth Rs m35,02717,171 204.0%   
Long term debt Rs m1,21216 7,572.5%   
Total assets Rs m54,38730,620 177.6%  
Interest coverage x13.6NM-  
Debt to equity ratio x00 3,712.4%  
Sales to assets ratio x0.90.9 99.8%   
Return on assets %13.612.3 111.1%  
Return on equity %19.221.9 88.0%  
Return on capital %24.933.6 74.0%  
Exports to sales %12.90 91,087.6%   
Imports to sales %3.115.1 20.5%   
Exports (fob) Rs m6,4614 161,527.5%   
Imports (cif) Rs m1,5404,237 36.4%   
Fx inflow Rs m6,563519 1,264.6%   
Fx outflow Rs m3,0128,320 36.2%   
Net fx Rs m3,552-7,801 -45.5%   
CASH FLOW
From Operations Rs m7,2591,386 523.9%  
From Investments Rs m1,8645,010 37.2%  
From Financial Activity Rs m-9,273-6,383 145.3%  
Net Cashflow Rs m-15012 -1,271.2%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 33.1 10.2 324.5%  
FIIs % 0.0 23.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 15.4 -  
Shareholders   68,381 102,036 67.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   JUBILANT LIFE SCIENCES  PLETHICO PHARMA  WOCKHARDT LTD.  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Vishal Sikka's Infosys Exit, White House Shake up & Cues to Watch Out Today(Pre-Open)

Indian share markets ended lower on Friday but gained during the overall week. At the closing bell on Friday, BSE Sensex closed lower by 271 points and the NSE Nifty finished down 67 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 18, 2017 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS